Testing effectiveness (Phase 2)Looking for participantsNCT07485296
What this trial is testing
Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)
Who this might be right for
Head & Neck Squamous Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 45